Approved Project
Novel therapeutic development
Keyword(s): therapeutic development, triple negative breast cancer
Year: 2025
Approved Project
Developing a new blood-based test to diagnose breast cancer
Keyword(s): diagnosis, biomarkers, blood test
Year: 2025
Approved Project
FASN in patients with TNBC that metastasized to the brain
Keyword(s): triple-negative breast cancer, fatty acid synthase, microenvironment, plasma, lipidomics, metastasis prevention
Year: 2025
Approved Project
Investigating Surface Expression of Nucleolin in Breast Cancer
Keyword(s): Nucleolin, breast cancer, surface expression, immunohistochemistry, biomarker, therapeutic target
Year: 2025
Approved Project
Establishing the functional role of driver mutations in the pathogenesis of Triple Negative Breast Cancer
Keyword(s): Breast cancer, stem cells, organoids, mutations, targeted therapy, biomarkers
Year: 2025
Approved Project
Negative Expression of Thymidylate Synthase (TYMS), O-6-Methylguanine-DNA Methyltransferase (MGMT), and BCL-2 as Theranostic Biomarkers in Triple Negative Breast Cancer Patients
Keyword(s): Identification of biomarkers in triple negative breast cancer, Triple Negative Breast Cancer (TNBC) Theranostic Biomarkers TYMS (Thymidylate Synthase) MGMT (O6-Methylguanine-DNA Methyltransferase) BCL-2 Negative Expression Personalized Medicine Predictive Biomarkers Targeted Therapy Drug Resistance
Year: 2025
Approved Project
Multiplex detection of a microRNA in breast cancer
Keyword(s): breast cancer, microRNA, biomarker, metastasis
Year: 2025
Approved Project
Obesity and Breast Cancer: a link between leptin and IGFBP-2
Keyword(s): proliferation, migration, IGFBP-2, leptin, colony forming assay
Year: 2025
Approved Project
3D imaging of DCIS
Keyword(s): DCIS 3D spatial imaging
Year: 2025
